Journal of Cancer 2021, Vol. 12 1936 Ivyspring International Publisher Journal of Cancer 2021; 12(7): 1936-1944. doi: 10.7150/jca.53675 Research Paper Prognostic significance of FSCN family in multiple myeloma Cong Deng1*, Chaozeng Si2*, Xu Ye3, Qiang Zhou1, Tiansheng Zeng3,4,5, Zeyong Huang3,4,5, Wenhui Huang3,4,5, Pei Zhu3,4,5, Qingfu Zhong3,4,5, Zhihua Wu3,4,5, Huoyan Zhu3,4,5, Qing Lin3,4,5, Wenjuan Zhang3,4,5, Lin Fu3,4,5,6,7, Yongjiang Zheng8, Tingting Qian3,4,5 1. Department of Clinical laboratory, The Second Affiliated Hospital, Guangzhou Medical University, 510260 Guangzhou, China. 2. Department of Information Center, China-Japan Friendship Hospital, 100029 Beijing, China. 3. Department of Hematology, The Second Affiliated Hospital, Guangzhou Medical University, 510260 Guangzhou, China. 4. Translational Medicine Center, State Key Laboratory of Respiratory Disease, The Second Affiliated Hospital of Guangzhou Medical University, 510260 Guangzhou, China. 5. Guangdong Provincial Education Department Key Laboratory of Nano-Immunoregulation Tumor Microenvironment, The Second Affiliated Hospital of Guangzhou Medical University, 510260 Guangzhou, China. 6. Translational Medicine Center, Huaihe Hospital of Henan University, 475000 Kaifeng, China. 7. Department of Hematology, Huaihe Hospital of Henan University, 475000 Kaifeng, China. 8. Department of Hematology, Institute of Hematology, The Third Affiliated Hospital of Sun Yat-Sen University, 510630 Guangzhou, China. * These authors contributed equally to this work: Cong Deng, Chaozeng Si. Corresponding author: Lin Fu, MD. PhD. E-mail:
[email protected]; Yongjiang Zheng, MD. PhD. E-mail:
[email protected]; Tingting Qian. E-mail:
[email protected]. © The author(s).